Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Pharmaceutical composition comprising a dual antagonist against PGD2/TXA2 receptors having a [2.2.1] or [3.1.1] bicyclic skeleton

US Patent 7105564 · Granted Sep 12, 2006

Estimated economic value: $15,534,000

Assignee

Inventors

View full patent text on Google Patents →